The Strategic Importance of This Tender
This success marks a major strategic turning point for RebrAIn, as the Resah procurement center plays a key role in the public healthcare sector in France. By enabling the member hospitals to choose the most effective technologies, it contributes to the continuous improvement of patient care. Winning this tender means our technology can be deployed across the entire French hospital network, meeting the needs of institutions seeking innovative solutions to enhance their clinical practices and optimize costs.
Let’s highlight what sets us apart:
- Optimized targeting: Improved clinical outcomes for patients by locating precise markers in the brain, thereby validating neurosurgeons’ planning.
- Enhanced workflow: A simple upload of a 1.5T or 3T MRI, followed by the rapid generation of an enriched image with markers indicating the optimal target.
- Cost-effective and accessible solution: No expensive equipment is required. Our fully online service offers affordable per-unit or annual fees, making cutting-edge technologies accessible toall institutions.
A Decisive Turning Point for RebrAIn
This new listing represents a decisive step in our development strategy, not only to strengthen our presence in the French market but also to increase our visibility internationally. It is a strong validation of our technology. Furthermore, it paves the way for future collaborations with other players in the hospital sector and greater recognition of our expertise in neurosurgery and artificial intelligence. We would like to express our gratitude to our partners: Karista, NACO, the Nouvelle-Aquitaine Region, France Biotech, and Bpifrance for their unwavering support.
